Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-252

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 25021-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Mit09 0000 01)

Chemical structure diagram of Mitomycin, showing the molecular arrangement with labeled atoms and bonds consistent with the Mitomycin molecule.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Mit09 0000 02)

Mitomycin for Injection, USP 40 mg per vial, single-dose vial for intravenous administration. The label highlights that the product is sterile, pyrogenic and preservative-free, made with natural rubber latex. It includes warnings about intravenous administration to avoid tissue damage and notes that it is a cytotoxic agent. The label also provides storage instructions and manufacturer information for Sagent Pharmaceuticals, Schaumburg, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.